These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15345605)

  • 1. Stopping clinical trials early.
    Grant A
    BMJ; 2004 Sep; 329(7465):525-6. PubMed ID: 15345605
    [No Abstract]   [Full Text] [Related]  

  • 2. Stopping rules for clinical trials.
    Whitehead J
    Control Clin Trials; 2004 Feb; 25(1):69-70; author reply 71-2. PubMed ID: 14980750
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for expanded monitoring of adverse events in behavioral health clinical trials.
    Peterson AL; Roache JD; Raj J; Young-McCaughan S;
    Contemp Clin Trials; 2013 Jan; 34(1):152-4. PubMed ID: 23117077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data Safety Monitoring Board (DSMB).
    Welch KM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():46-7. PubMed ID: 15512871
    [No Abstract]   [Full Text] [Related]  

  • 5. Data monitoring and large apparent treatment effects.
    Korn EL; Freidlin B; George SL
    Control Clin Trials; 2004 Feb; 25(1):67-9; author reply 71-2. PubMed ID: 14980749
    [No Abstract]   [Full Text] [Related]  

  • 6. Stopping clinical trials by design.
    Whitehead J
    Nat Rev Drug Discov; 2004 Nov; 3(11):973-7. PubMed ID: 15520819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stopping trials for benefit can (sometimes) benefit patients.
    Pater JL; Goss P; Meyer R
    J Clin Oncol; 2008 Jun; 26(16):2787-8; author reply 2788. PubMed ID: 18509191
    [No Abstract]   [Full Text] [Related]  

  • 9. Information-based monitoring of clinical trials.
    Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3236-44; discussion 3320-5, 3326-47. PubMed ID: 16927248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current controversies in data monitoring for clinical trials.
    Pocock SJ
    Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 13. Early stopping of clinical trials.
    Cuzick J; Howell A; Forbes J
    Breast Cancer Res; 2005; 7(5):181-3. PubMed ID: 16168134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Empty cardboard boxes and lobbyism].
    Bach KF
    Ugeskr Laeger; 2011 Jan; 173(2):105. PubMed ID: 21219839
    [No Abstract]   [Full Text] [Related]  

  • 15. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard 3: data monitoring committees.
    Ellenberg S; Fernandes RM; Saloojee H; Bassler D; Askie L; Vandermeer B; Offringa M; Van der Tweel I; Altman DG; van der Lee JH;
    Pediatrics; 2012 Jun; 129 Suppl 3():S132-7. PubMed ID: 22661759
    [No Abstract]   [Full Text] [Related]  

  • 17. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial registration.
    Harms M
    Physiotherapy; 2011 Sep; 97(3):181. PubMed ID: 21820534
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group.
    Gallo P; Chuang-Stein C; Dragalin V; Gaydos B; Krams M; Pinheiro J;
    J Biopharm Stat; 2006 May; 16(3):275-83; discussion 285-91, 293-8, 311-2. PubMed ID: 16724485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.